Expand GANX Menu
GANX MENU

GANX Latest Press Releases

-- June 29, 2026 --

Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson's Disease Globe Newswire 4:05 PM

-- June 10, 2026 --

Gain Therapeutics to Present at H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit Globe Newswire 7:00 AM

-- May 26, 2026 --

Gain Therapeutics Presents Positive Interim Data from Phase 1b Clinical Study of GT-02287 at 3rd International GBA1 Meeting 2026 Globe Newswire 8:00 AM

-- May 11, 2026 --

Gain Therapeutics Reports Financial Results for First Quarter 2026 and Provides Corporate Update Globe Newswire 7:00 AM

-- April 24, 2026 --

Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026 Globe Newswire 8:30 AM

-- March 26, 2026 --

Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2025 and Provides Corporate Update Globe Newswire 7:00 AM

-- March 19, 2026 --

Gain Therapeutics to Present at the 38th Annual ROTH Conference Globe Newswire 4:57 PM

-- March 18, 2026 --

Gain Therapeutics Presents Additional Clinical and Biomarker Data from Phase 1b Clinical Study of GT-02287 and Preclinical Data from Novel Chemical Series at AD/PD 2026 Globe Newswire 8:15 AM

-- March 12, 2026 --

Gain Therapeutics Announces Presentations at AD/PDTM 2026 and Provides U.S. FDA Regulatory Update Globe Newswire 7:00 AM

-- February 19, 2026 --

Gain Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes